Healthcare Services

DNA Sequencing Market Insights Exploring Expansion Opportunities Through 2030

May 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The DNA Sequencing Market?

The dna sequencing market has shown substantial growth recently. It is set to expand from $15.8 billion in 2025 to $18.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 16.2%. This historical growth is largely due to the completion of the human genome project, declining sequencing costs, the rise of academic genomics research, demand from pharmaceutical R&D, and the early adoption of sanger sequencing.

The dna sequencing market is projected for substantial expansion in the coming years. Its size is anticipated to climb to $34.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.8%. This growth during the forecast period is primarily driven by factors such as the expansion of precision medicine, population genomics initiatives, AI-enabled data analysis, the increase in oncology diagnostics, and support for clinical sequencing reimbursement. Significant trends anticipated within this period involve the rising adoption of next-generation sequencing technologies, the broadened application of sequencing in clinical diagnostics, its increasing utilization in cancer and rare disease research, the integration of sequencing with bioinformatics platforms, and a growing demand for high-throughput sequencing services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12604&type=smp

Which Growth Drivers Are Expected To Support The DNA Sequencing Market Forward?

The rising incidence of cancer is projected to drive expansion within the DNA sequencing market in the future. Cancer describes the uncontrolled proliferation and dissemination of aberrant cells capable of invading or damaging healthy tissues in different organs. An increase in cancer cases is observed, attributable to factors such as aging demographics, lifestyle-related risks, environmental influences, and more effective diagnostic techniques. The DNA sequencing market facilitates this trend by allowing for the discovery of genetic alterations, providing a more profound insight into tumor characteristics, and enabling tailored treatment choices that enhance patient recovery. As an illustration, in January 2024, data from the American Cancer Society, a US-based nonprofit cancer advocacy organization, indicated that cancer diagnoses climbed to 2,001,140 in 2024, an increase from 1,958,310 in 2023, which represents a 2.19% surge. Consequently, the growing occurrence of cancer is a key impetus for the expansion of the DNA sequencing market.

How Is The DNA Sequencing Market Distributed Across Key Segments?

The dna sequencing market covered in this report is segmented –

1) By Product: Instruments, Consumables, Services

2) By Technology: Third Generation DNA Sequencing, Next-Generation Sequencing, Sanger Sequencing

3) By Application: Diagnostics, Biomarkers And Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications

4) By End User: Hospitals And Healthcare Organizations, Academics And Research Institutions, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Single-Molecule Sequencing Instruments

2) By Consumables: Reagents, Kits, Chips And Flow Cells

3) By Services: Sequencing Services, Data Analysis Services, Bioinformatics Services

Which Trends Are Guiding The Development Of The DNA Sequencing Market?

Leading companies within the global DNA sequencing market are concentrating on developing innovative platforms, specifically compact, affordable benchtop sequencers and real-time analysis solutions. This strategic focus aims to broaden accessibility, accelerate turnaround times, and enhance the scalability of genomic testing. These cutting-edge sequencing platforms are next-generation instruments and software systems engineered to reduce the cost per genome, increase throughput, support decentralized testing, and provide faster results for clinical and research applications. For instance, in October 2024, Illumina Inc., a US-based biotechnology company, announced the introduction of its new MiSeq i100 gene sequencers. These smaller, lower-cost benchtop devices are capable of generating results in approximately four hours and are priced at USD 49,000 for the base model. This initiative is designed to make high-throughput sequencing accessible to a greater number of research and testing laboratories, thereby fostering innovation throughout DNA sequencing. These compact systems deliver enhanced efficiency without compromising data quality, and their affordability allows smaller institutions to adopt advanced sequencing technologies that were previously beyond their reach.

Which Organizations Are Involved In The DNA Sequencing Market?

Major companies operating in the dna sequencing market are F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics, Myriad Genetics Inc., Natera Inc., 10x Genomics Inc., GenScript Biotech Corporation, Novogene Corporation, Twist Bioscience, Genewiz LLC, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Macrogen Inc., LI-COR Inc., MGI Tech Co. Ltd., Zymo Research Corporation, Igenomix, Codex DNA, GenapSys Inc., SeqOnce Biosciences Inc.

Access The Complete DNA Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Which Region Is The Primary Market For The DNA Sequencing Market?

North America was the largest region in the DNA sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access DNA Sequencing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=12604&type=smp

Browse Through More Reports Similar to the Global DNA Sequencing Market 2026, By The Business Research Company

Prenatal Dna Sequencing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prenatal-dna-sequencing-global-market-report

Protein Sequencing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/protein-sequencing-global-market-report

Next Generation Sequencing Market 2026

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795